Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

62.4K
Overview
62.4K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.3K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

849
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
849
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

920
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
920
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration.

Journal of extracellular vesicles·2026
Same author

Transcriptional profiles of immature neurons in aged human hippocampus track Alzheimer's pathology and cognitive resilience.

Cell stem cell·2026
Same author

Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial.

Research and practice in thrombosis and haemostasis·2026
Same author

Endogenous Repair in Vanishing White Matter.

Annals of neurology·2025
Same author

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.

Molecular therapy. Methods & clinical development·2025
Same author

Unexpected Remyelination in the Absence of Matrix Metalloproteinase 7.

Glia·2025

Related Experiment Video

Updated: Feb 13, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K

Inflammation in CNS neurodegenerative diseases.

Jodie Stephenson1,2, Erik Nutma2, Paul van der Valk2

  • 1Centre for Neuroscience and Trauma, Barts and the Blizard Institute, London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Immunology
|March 8, 2018
PubMed
Summary

Neuroinflammation, driven by the brain

Keywords:
immune responseinflammationmicrobiomeneuroprotectionrepair

More Related Videos

Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.7K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Related Experiment Videos

Last Updated: Feb 13, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K
Olfactory Assays for Mouse Models of Neurodegenerative Disease
07:27

Olfactory Assays for Mouse Models of Neurodegenerative Disease

Published on: August 25, 2014

22.7K
Interview: Protein Folding and Studies of Neurodegenerative Diseases
19:50

Interview: Protein Folding and Studies of Neurodegenerative Diseases

Published on: July 16, 2008

13.2K

Area of Science:

  • Neuroimmunology
  • Neurodegenerative Diseases
  • Central Nervous System (CNS) Immunity

Background:

  • Neurodegenerative diseases like Alzheimer's and Parkinson's are major causes of disability, exacerbated by an aging population.
  • Neuronal damage in these diseases, despite varied causes (infections, genetics, trauma), is often linked to chronic CNS innate immune activation.
  • The immune system plays a critical role in brain development, damage, regeneration, and repair, highlighting its relevance to neurodegenerative conditions.

Purpose of the Study:

  • To review the current understanding of neuroimmune responses during development and disease.
  • To explore the roles of astrocytes, microglia, neurons, and oligodendrocytes in shaping neuroimmunity.
  • To discuss the implications of aberrant neuroimmune responses for CNS predisposition to neurodegenerative diseases.

Main Methods:

  • Review of current scientific literature on neuroimmunology and neurodegenerative diseases.
  • Analysis of the roles of glial cells (astrocytes, microglia) and neurons in the neuroimmune response.
  • Examination of interactions between the peripheral immune system and the CNS, including immune cell trafficking.

Main Results:

  • Aberrant neuroimmune responses, triggered by genetic or environmental factors, can predispose the CNS to neurodegenerative diseases.
  • Understanding glial cell (astrocytes, microglia) and neuron interactions is crucial for comprehending neuroimmune function.
  • Peripheral immune system interactions and CNS immune cell dynamics are key aspects of neuroinflammation.

Conclusions:

  • Modulating the neuroimmune system presents a promising therapeutic avenue for neurodegenerative diseases.
  • A deeper understanding of neuroimmune interactions is essential for developing effective treatments.
  • Targeting neuroinflammation can improve quality of life and reduce the burden of neurodegenerative and inflammatory CNS diseases.